Mounjaro and hypothyroidism: what the evidence says

The situation most people with hypothyroidism are actually in

You've probably spent years managing your thyroid levels, adjusting levothyroxine doses whenever your TSH drifts, and dealing with the frustrating reality that an underactive thyroid often makes weight harder to shift. Now you've heard about tirzepatide and you want to know if it's off the table for you.

For the majority of people with hypothyroidism (those whose levels are stable on replacement therapy and who are otherwise in reasonable health) the condition itself is not listed as a contraindication in the Mounjaro Summary of Product Characteristics on the eMC. What a prescriber is looking for is whether your thyroid function is controlled, whether you're on a settled dose of levothyroxine, and whether there are other factors in your history that change the risk calculation.

The contraindication that does exist around thyroid tissue is specific: tirzepatide is not suitable for anyone with a personal or family history of medullary thyroid carcinoma, or MEN2 (Multiple Endocrine Neoplasia type 2). This relates to findings in animal studies, where GLP-1 receptor agonists triggered C-cell tumours in rodents at high doses. Whether the same risk translates to humans is not established, but UK prescribers follow the precautionary line. If you have hypothyroidism from an autoimmune cause (Hashimoto's thyroiditis), this is a different part of the thyroid and the MTC contraindication does not apply to you, though your full history should still be shared with your prescriber.

How Mounjaro's mechanism affects thyroid replacement therapy

Tirzepatide is a dual GIP and GLP-1 receptor agonist. One of the things it does reliably is slow gastric emptying, which is part of how it reduces appetite. That same effect, however, can alter the rate at which oral medicines are absorbed. Levothyroxine is one of the more absorption-sensitive medicines in common use: it's typically taken first thing in the morning, on an empty stomach, at least 30 minutes before food, coffee or other tablets, precisely because anything that interferes with absorption can shift your thyroid levels.

There is no direct pharmacokinetic study on tirzepatide and levothyroxine that has been published as part of the core UK licence dossier, but this interaction potential is the reason prescribers will often flag it. The NHS medicines page for tirzepatide notes that this class of medicine can affect how other drugs are absorbed. If you take levothyroxine, your prescriber may advise that your GP checks your thyroid function after you begin tirzepatide, especially once you start losing meaningful amounts of weight, because even weight loss itself can alter how much levothyroxine you need.

For practical detail on the levothyroxine question specifically, our page on taking Mounjaro alongside levothyroxine goes into the evidence in more depth.

What's still uncertain, and who should be in that conversation

Clinical evidence specifically in people with hypothyroidism is limited. The large SURMOUNT-1 trial (which showed meaningful average weight loss at 15mg over 72 weeks) enrolled a broad population, but the data isn't broken out by thyroid status in most published analyses. That doesn't mean tirzepatide works differently in people with hypothyroidism; it means the condition-specific literature hasn't fully caught up with the medicine yet.

There's also the question of whether getting your thyroid levels right first changes your results on tirzepatide. Hypothyroidism can contribute to weight gain independently of what you eat, and there's logic to ensuring your levels are optimised before assessing how any weight-loss treatment performs. This is genuinely a prescriber-level conversation, and ideally one that involves your GP or endocrinologist if your thyroid history is complex.

If you have hyperthyroidism rather than an underactive thyroid, the picture is different again, our page on Mounjaro and hyperthyroidism covers that specific situation. And if you've been searching specifically about Mounjaro for people with an underactive thyroid, that underactive thyroid page addresses the same questions from a slightly different angle.

The practical path from here

If you have hypothyroidism and are considering Mounjaro for weight management, here's a reasonable way to think about next steps. First, check that your current thyroid levels are stable, if your TSH hasn't been tested recently, it's worth asking your GP before starting anything new. Second, make sure whoever reviews your consultation knows your full thyroid history, your current levothyroxine dose, and any other conditions or medicines. Third, be prepared for a conversation about monitoring: your prescriber or GP may want to check your thyroid function a few months into treatment, particularly if your weight drops noticeably, and our guide on how often you can take Mounjaro explains the dosing schedule that sits alongside that monitoring.

The broader eligibility picture for Mounjaro (BMI thresholds, weight-related conditions, and how those feed into a clinical assessment) is covered on our Mounjaro BMI eligibility page, and there's a fuller overview of who can take Mounjaro in the UK if you want the wider context. Mounjaro is not suitable for use during pregnancy, breastfeeding, or if you are actively trying to conceive, and it is not licensed for anyone under 18, those exclusions apply regardless of thyroid history.

At nume, every consultation is read by a GPhC-registered Independent Prescriber, a named clinician who considers your health picture in full, including any thyroid condition. If you'd like to see whether treatment is right for you, check your eligibility through a free consultation. And if timing matters (you want to get started before a long holiday or a busy month ahead) orders placed by 12pm Monday to Friday are dispatched the same day once approved, with free next-working-day tracked delivery.